Benutzer: Gast  Login
Mehr Felder
Einfache Suche
Titel:

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes.

Dokumenttyp:
Journal Article; Review
Autor(en):
Tschöpe, Diethelm; Hanefeld, Markolf; Meier, Juris J; Gitt, Anselm K; Halle, Martin; Bramlage, Peter; Schumm-Draeger, Petra-Maria
Abstract:
Metformin is, if not contraindicated and if tolerated, usually preferred over other antidiabetic drugs for the first line treatment of type-2 diabetes. The particular decision on which antidiabetic agent to use is based on variables such as efficacy, cost, potential side effects, effects on weight, comorbidities, hypoglycemia, risk, and patient preferences. However, there is no guidance how to consider these in the selection of antidiabetic drug treatment. In this work, we aimed to summarize ava...     »
Zeitschriftentitel:
Cardiovasc Diabetol
Jahr:
2013
Band / Volume:
12
Seitenangaben Beitrag:
62
Sprache:
eng
Volltext / DOI:
doi:10.1186/1475-2840-12-62
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/23574917
Print-ISSN:
1475-2840
TUM Einrichtung:
Poliklinik für Präventive und Rehabilitative Sportmedizin
 BibTeX